(Q24245505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

1 reference

title

Systemic administration of local anesthetic agents to relieve neuropathic pain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

V Challapalli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

I W Tremont-Lukats

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

E D McNicol

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

J Lau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

D B Carr

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

19 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

CD003345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Systemic lidocaine in pain due to peripheral nerve injury and predictors of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Effect of mexiletine on spinal cord injury dysesthetic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Intravenous lidocaine infusion--a new treatment of chronic painful diabetic neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

The analgesic effect of tocainide in trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Lidocaine test in neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Analgesic effects of intravenous lidocaine and morphine on postamputation pain: a randomized double-blind, active placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Differential effects of systemically administered ketamine and lidocaine on dynamic and static hyperalgesia induced by intradermal capsaicin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Controlled study of pain relief by intravenous procaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Mexiletine for thalamic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Analgesic responses to i.v. lignocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

What decline in pain intensity is meaningful to patients with acute pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Defining the clinically important difference in pain outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Systemic local-anaesthetic-type drugs in chronic pain: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Quantitative Synthesis in Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Systemic lidocaine for neuropathic pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Lignocaine selectively reduces C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated post-synaptic depolarizations; implications for the development of novel centrally acting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Pharmacologic treatment of pain in polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

The quantification of pain: an analysis of words used to describe pain and analgesia in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003345.PUB2

Intravenous lidocaine, amantadine, and placebo in the treatment of sciatica: a double-blind, randomized, controlled study

21 January 2018

1 reference

12 December 2020

Efficacy of oral mexiletine for neuropathic pain with allodynia: a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

Effect of oral mexiletine on capsaicin-induced allodynia and hyperalgesia: a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

The power of statistical tests in meta-analysis

1 reference

12 December 2020

The analgesic effect of gabapentin and mexiletine after breast surgery for cancer

1 reference

12 December 2020

The Use of Oral Mexiletine for the Treatment of Pain after Peripheral Nerve Injury

1 reference

12 December 2020

Intravenous lignocaine anaesthesia.

1 reference

12 December 2020

Xylocaine for the relief of postoperative pain.

1 reference

12 December 2020

Mexiletine in the treatment of diabetic neuropathy

1 reference

12 December 2020

Intravenous use of xylocaine

1 reference

12 December 2020

Using the "TOPS," an outcomes instrument for multidisciplinary outpatient pain treatment

1 reference

12 December 2020

Neurogenic pain syndromes and their management

1 reference

12 December 2020

Trial of intravenous lidocaine on painful neuropathy in cancer patients

1 reference

12 December 2020

Chronic pain treatment with intravenous lidocaine.

1 reference

12 December 2020

Mexiletine for treatment of chronic painful diabetic neuropathy

1 reference

12 December 2020

Analgesic effects of oral flecainide

1 reference

12 December 2020

Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion

1 reference

12 December 2020

Reduction of hyperpathia indicates pain relief

1 reference

12 December 2020

Lidocaine as an analgesic for experimental pain.

1 reference

12 December 2020

[Mexiletine in treatment of painful diabetic neuropathy]

1 reference

12 December 2020

Mexiletine in the Symptomatic Treatment of Diabetic Peripheral Neuropathy

1 reference

12 December 2020

Efficacy and Safety of Mexiletine in the Treatment of Painful Diabetic Neuropathy. The Mexiletine Study Group

1 reference

12 December 2020

Problems in the “Evidence” of “Evidence-Based Medicine”

1 reference

12 December 2020

The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain.

1 reference

12 December 2020

10.1002/14651858.CD003345.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1569838

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

OpenCitations bibliographic resource ID

8 January 2020

1569838

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

PubMed publication ID

16235318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235318%20AND%20SRC:MED&resulttype=core&format=json